Clinical Trials Logo

Clinical Trial Summary

Mucosal healing or histological remission is an important target for the treatment of inflammatory bowel disease. In this study, patients with mucosal healing are defined as a control group, observing their clinical outcomes for 3 years, and describing the recurrence rate. The secondary objective is to study the operative rate, glucocorticoid utilization rate, treatment escalation rate, hospitalization rate and incidence of related complications.


Clinical Trial Description

Assess the health condition of patients for 1year, 2year,3year and analyze outcomes and complications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03698812
Study type Observational
Source Nanfang Hospital of Southern Medical University
Contact Xinying Wang, MD
Phone 13726754880
Email sunwingwxy@163.com
Status Recruiting
Phase
Start date January 1, 2017
Completion date September 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT01257399 - Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase Phase 3
Completed NCT01301976 - Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis N/A
Terminated NCT03122613 - Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis N/A
Recruiting NCT03501758 - Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound
Recruiting NCT04695964 - Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis N/A
Completed NCT05656391 - Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis N/A